In a significant move to bolster its leadership team, Tobin Scientific has appointed Dr. Graham Long as its new Chief Commercial Officer. This decision marks a pivotal moment for the company as it prepares for a new phase of growth following a successful $65 million funding round. Dr. Long's extensive background in the life sciences industry aligns perfectly with the company's ambition to expand its geographic and operational reach in cGMP storage, biorepository services, and specialized logistics.
Dr. Long brings more than 20 years of experience in commercial and scientific roles, having successfully driven growth strategies for both small and large life sciences firms across the United States and internationally. Most recently, he served as Principal Partner at BioKresko, where he offered strategic consulting and business development insights tailored for life sciences organizations. His prior role as Vice President of Client Solutions at SmartLabs put him at the forefront of innovation, leading a large commercial team that achieved remarkable triple-digit revenue increases and established significant contracts with leading pharmaceutical companies.
Educationally equipped with a Ph.D. in Clinical Biochemistry and Molecular Biology from the University of Cambridge and a Bachelor of Science in Applied Biochemistry from Brunel University in London, Dr. Long possesses a well-rounded academic and practical understanding of both the operational and commercial facets of the medications industry. His global experience encompasses Europe, Asia, and Oceania, making him a valuable asset to TobinScientific as it seeks to broaden its horizons in the biopharma market.
Brian Tobin, the CEO of Tobin Scientific, expressed his enthusiasm regarding this appointment: "Graham is a rare hybrid of science and strategy. His profound understanding of the biopharma landscape, combined with his keen commercial instincts, is precisely what we require as we pursue growth in new markets and diversify our services."
As the Chief Commercial Officer, Dr. Long will oversee all facets of commercial operations, focusing on sales strategy and client partnerships while spearheading business development in critical areas such as laboratory logistics, cold chain transport, and GxP storage solutions. His expertise in the pharmaceutical supply chain will be particularly instrumental as Tobin Scientific embarks on its next growth initiative.
"Joining Tobin Scientific at this juncture is incredibly compelling," Dr. Long commented. "The team's energy is palpable, ambitions are monumental, and the path for growth is distinctly outlined. I am eager to scale our presence in biorepository, storage, and biopharma logistics, both organically and through smart acquisitions across the Northeast and further afield."
Tobin Scientific stands as a trusted name in the domain of biopharma cold chain, ambient storage, and transport logistics services. With decades of experience and a national presence, Tobin offers an expansive suite of services, from laboratory relocations to cold chain transportation, and operates multiple warehouses exceeding 300,000 square feet of cGMP and biorepository storage. The company prides itself on ensuring the secure and efficient transport and storage of temperature-sensitive products, making it a leader in its field. For more details about their services and operations, visit
TobinScientific.com.